Researchers from the Organic and Medical Chemistry group at the Universitat Jaume I (OrgMedChem), coordinated by Florenci González Adelantado, are working on the development of new antiviral molecules against SARS-CoV-2. Specifically, the aim of the project is to have specific cysteine protease inhibitors for SARS-CoV-2 proteases that will serve as innovative therapy against COVID-19. Read More
The University of Valencia (UV), the Institute of Biomedicine of Valencia (IBV) of the CSIC and the Carlos III Health Institute (ISCIII) are researching the molecular mechanism by which the SARS-CoV-2 virus assembles virions (morphologically complete particles but not contagious since they do not contain the viral RNA) in the cells infected with COVID-19. The study is analysing the membrane proteins (that when separated would cause the destruction of the cell envelope) and has been funded in the ISCIII FONDO-COVID19 call, aimed at supporting research projects on the virus and the disease it causes. Read More
Researchers from the Molecular Science Institute (ICMol) of the University of Valencia are participating in REMADYL, a Horizon 2020 project that consists of developing materials to capture and eliminate PVC lead stabilisers at the end of their useful life and the later use of said lead in the manufacturing of batteries. The work is part of the European line of transition towards a green economy and society through ecological innovation. Read More
The Institutional Legal Clinical Chair at the Miguel Hernández University of Elche (UMH), which operates under the institution’s Vice-Rectorate for Institutional Relations, has coordinated the production of the Basic Legal Guide to COVID-19, which aims to clarify the issues and terminology that are currently most concerning to people who are non-experts on legal matters. Their guide provides information in the form of questions frequently asked about different aspects of occupational, contractual, economic, and family matters following the declaration of the State of Emergency in Spain and the establishment of confinement measures. Read More
The Crímina Research Centre at the Miguel Hernández University of Elche (UMH) is preparing a study that aims to determine the factors that influence whether or not people decide to remain confined within their home, which became obligatory in Spain following the declaration of the State of Emergency on 14 March. The fear of contagion, house size and harsh monetary fines, are some of the issues raised in this research as variables that may affect decisions on whether to remain at home or not, with the objective of preventing the latter.
The authors of this study include the director of the UMH Crímina Research Centre, Fernando Miró, a researcher from this Centre, Ana Belén Gómez, and Steven Kemp, a researcher from the University of Girona. In addition to Spain, this research is also ongoing in a similar manner in the United Kingdom, which will enable comparisons of the data between the outcomes of the Spanish and British samples.
Since the declaration of the State of Emergency on 14 March 2020, most of Spain’s population has had their freedom of movement restricted by having to remain confined within their homes, with only certain exceptions. Among others, these exceptions include going to the supermarket, purchasing tobacco, walking pets, working with due authorization, and always respecting basic recommendations. However, data provided by Spanish law enforcement agencies indicate that a portion of the population has been infringing upon the rules of confinement, either by ignoring their obligations of remaining at home or by abusing the exceptional cases that allow them to go outside. The authors of this study have prepared a survey that includes a set of variables that may influence the population’s decision process on whether or not to abide by the confinement.
Anybody interested in participating in this research may do so by completing this survey. To encourage participation, €50 vouchers for purchases on Amazon will be drawn and awarded to five participants.
The Carlos III Health Institute (ISCIII) has certified the COVID-19 PCR diagnostic service launched by the University of Valencia and biotechnology company Epidisease. The laboratory, which has the means to analyse 1,200 viral samples a day, will provide its services to the Department of Universal and Public Health by analysi¡ng samples from Valencian hospitals. Read More